科华数据(002335) - 2022 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2022 was ¥993,271,724.12, representing a 2.38% increase compared to ¥970,188,549.03 in the same period last year[3]. - The net profit attributable to shareholders was ¥98,096,046.28, up 2.71% from ¥95,505,263.80 year-on-year[3]. - The net profit after deducting non-recurring gains and losses was ¥85,549,853.25, showing a slight decrease of 0.86% from ¥86,287,618.95 in the previous year[3]. - Total operating revenue for the current period reached ¥993,271,724.12, an increase from ¥970,188,549.03 in the previous period, reflecting a growth of approximately 2.2%[22]. - Net profit for the current period was ¥101,733,062.96, compared to ¥97,849,933.75 in the previous period, representing a growth of approximately 4.3%[22]. - The net profit attributable to the parent company was ¥98,096,046.28, an increase from ¥95,505,263.80, showing a growth of around 2.7%[25]. - The company reported a total comprehensive income of ¥101,733,062.96 for the current period, compared to ¥97,849,933.75 in the previous period, indicating an increase of about 4.3%[25]. - Basic earnings per share remained stable at ¥0.21 for both the current and previous periods[25]. Cash Flow - The net cash flow from operating activities improved significantly to ¥8,328,715.44, a 111.01% increase from a negative cash flow of ¥75,633,004.24 in the same quarter last year[3]. - Cash inflow from operating activities amounted to ¥1,132,458,037.64, an increase from ¥1,041,923,717.77 in the previous period, reflecting a growth of approximately 8.7%[29]. - Net cash flow from operating activities was ¥8,328,715.44, a significant recovery from a negative cash flow of -¥75,633,004.24 in the prior period[29]. - Cash inflow from investment activities totaled ¥400,346,747.13, compared to ¥1,442,323.00 in the previous period, indicating a substantial increase in investment recovery[32]. - Net cash flow from investment activities was ¥91,119,697.47, recovering from a negative cash flow of -¥105,877,326.56 in the prior period[32]. - Cash inflow from financing activities was ¥281,166,827.56, down from ¥400,829,318.95 in the previous period, representing a decrease of approximately 29.8%[32]. - Net cash flow from financing activities was -¥127,400,207.23, an improvement from -¥263,334,663.00 in the prior period[32]. - The ending cash and cash equivalents balance was ¥436,730,568.65, compared to ¥304,209,469.86 in the previous period, showing an increase of approximately 43.5%[32]. - Total cash and cash equivalents decreased by ¥28,508,505.76 during the period, a significant improvement from a decrease of ¥444,889,437.17 in the prior period[32]. Assets and Liabilities - Total assets at the end of the reporting period were ¥9,396,828,923.72, down 1.82% from ¥9,571,292,317.69 at the end of the previous year[3]. - The company's total current assets at the end of the reporting period were approximately RMB 3.75 billion, down from RMB 3.85 billion at the beginning of the year[16]. - The total assets of the company amounted to approximately RMB 9.40 billion, a decrease from RMB 9.57 billion at the beginning of the year[16]. - The company's total non-current assets were approximately RMB 5.65 billion, down from RMB 5.73 billion at the beginning of the year[16]. - The total liabilities decreased to ¥5,579,380,003.01 from ¥5,852,313,643.35, a reduction of about 4.6%[22]. - The equity attributable to shareholders increased to ¥3,624,453,885.25, reflecting a growth of 2.74% from ¥3,527,869,342.57 at the end of the previous year[3]. - The total equity attributable to shareholders of the parent company rose to ¥3,624,453,885.25 from ¥3,527,869,342.57, reflecting an increase of approximately 2.7%[22]. Shareholder Information - The total number of common shareholders at the end of the reporting period was 73,108[9]. - The largest shareholder, Xiamen Kehua Weiye Co., Ltd., holds 19.73% of shares, totaling 91,055,442 shares[9]. - The second-largest shareholder, Chen Chenghui, owns 17.06% of shares, amounting to 78,723,124 shares, with 59,042,343 shares pledged[9]. Research and Development - Research and development expenses increased by ¥23,651,861.10, representing a 30.45% rise, indicating a focus on innovation[6]. - Research and development expenses increased to ¥59,758,707.47 from ¥46,427,616.36, marking a rise of approximately 28.6%[22]. Other Income - Other income rose by ¥3,405,298.91, a 33.70% increase, primarily due to additional government subsidies received[6]. - The company experienced a 46.21% increase in non-operating income, amounting to ¥770,108.11, attributed to claims and penalty income[6]. Employee and Tax Expenses - Employee compensation payments increased to ¥163,619,560.66 from ¥147,783,916.60, reflecting a rise of approximately 10.7%[29]. - Tax payments increased to ¥64,462,065.05 from ¥47,062,193.64, indicating a rise of approximately 37%[29]. Financial Management - The cash flow statement details will be provided in the subsequent report, indicating ongoing financial management efforts[28].